Intervention

Placebo injection

ClinicalTrials.gov intervention label

Clinical trials9

Recruiting1

Common conditions10

Lead sponsors shown9

Clinical trials

9 shown

Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac SurgeryNCT06361238 · 2024-11-19

Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese ParticipantsNCT07840729 · 2026-10-20

NOT_YET_RECRUITING

A Study of HS-20094 in Chinese Adults With Overweight or ObesityNCT06839664 · 2024-11-16

Effect of Stellate Ganglion Block on Drooling in Parkinson's SyndromeNCT06370195 · 2024-04-01

Effectiveness of Stellate Ganglion Block in Patients Diagnosed With Parkinson's DiseaseNCT06319625 · 2024-03-01

The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant PatientsNCT03419624 · 2018-02-19

Comparison of Vehicle Delivery Depth Using the NovoFine® 5 mm Needle With or Without a Skin Fold and Inserted at Either 45 or 90 DegreesNCT00894270 · 2008-11-01

An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyNCT00264550 · 2005-12-01

Regulation of Cortisol Metabolism and Fat PatterningNCT00694733 · 2005-05-01

Common conditions

Obesity3 Delirium, Postoperative1 Diabetes Mellitus1 Diabetes Mellitus, Type 21 Menopausal Syndrome1 Overweight1 Parkinson Disease1 Parkinson's Syndrome1 Rheumatoid Arthritis1 Valid MeSH Conditiongs1

Leading sponsors

Babujinaya Cela1 Centocor, Inc.1 Copka Sonpashan1 Jiangsu Hansoh Pharmaceutical Co., Ltd.1 Liggins Institute1 Oregon Health and Science University1 Shanghai JMT-Bio Inc.1 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1 Universitätsklinikum Hamburg-Eppendorf1

Trial status mix

COMPLETED3

UNKNOWN3

NOT_YET_RECRUITING1

RECRUITING1

TERMINATED1

Phase mix

PHASE34

NA3

PHASE11

PHASE41

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.